Stock listing
NASDAQ:RDEA Ardea Biosciences Inc Stock
Follow Ardea Biosciences Inc into a list and get an email when it puts out news.
Last close · NASDAQ:RDEA
$31.96 USD
Close on Jun 19, 2012 · No longer trades
- Lowest – highest close
- $1.71 – $382.65 USDSince Mar 28, 2000 · lowest May 15, 2003 · highest Jul 10, 2000
Delisted NASDAQ:RDEA no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:RDEA
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
Ardea Biosciences Inc on 6ix
- Decks
- 24 decks · latest Jan 9, 2012
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Corporate Update (January 2012) | Corporate update | 56 slides | Jan 9, 2012 |
| Corporate Update (November 2011) | Corporate update | 49 slides | Nov 7, 2011 |
| Technical Presentation (September 2011) | Technical | 6 slides | Sep 7, 2011 |
| Annual European Congress of Rheumatology EULAR 2011 | Conference | 34 slides | May 25, 2011 |
| Corporate Update (January 2011) | Corporate update | 13 slides | Jan 6, 2011 |
| Corporate Update (November 2010) | Corporate update | 37 slides | Nov 8, 2010 |
| Annual European Congress of Rheumatology EULAR 2010 | Conference | 22 slides | Jun 18, 2010 |
| Corporate Update (May 2010) | Corporate update | 35 slides | May 10, 2010 |
| Corporate Update (March 2010) | Corporate update | 27 slides | Mar 8, 2010 |
| Corporate Update (January 2010) | Corporate update | 40 slides | Jan 11, 2010 |
All 24 decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Corporate Update (December 2009) | Corporate update | 37 slides | Dec 1, 2009 |
| Corporate Update (November 2009) | Corporate update | 34 slides | Nov 3, 2009 |
| Corporate Update (October 2009) | Corporate update | 25 slides | Oct 19, 2009 |
| Corporate Update (September 2009) | Corporate update | 40 slides | Sep 11, 2009 |
| Investor Day (April 2009) | Investor day | 70 slides | Apr 20, 2009 |
| Corporate Update (March 2009) | Corporate update | 37 slides | Mar 16, 2009 |
| Corporate Update (January 2009) | Corporate update | 35 slides | Jan 16, 2009 |
| Corporate Update (December 2008) | Corporate update | 35 slides | Dec 18, 2008 |
| Shareholder Meeting (May 2008) | Shareholder meeting | 34 slides | May 23, 2008 |
| Corporate Update (March 2008) | Corporate update | 28 slides | Mar 18, 2008 |
| Investor Presentation (December 2007) | Investor deck | 38 slides | Dec 20, 2007 |
| Corporate Update (November 2007) | Corporate update | 34 slides | Nov 28, 2007 |
| Corporate Update (September 2007) | Corporate update | 42 slides | Sep 4, 2007 |
| Intrabiotics Pharmaceuticals — Investor Presentation (February 2003) | Investor deck | 19 slides | Feb 18, 2003 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Craig Johnson Other companies: Aurinia Pharmaceuticals Inc (Board Director · Since at least Nov 7, 2024); Heron Therapeutics, Inc. (Lead Independent Director · Since at least Jan 10, 2014); La Jolla Pharmaceutical Co (Director · Oct 14, 2013 – Aug 22, 2022 · Past); PURE Bioscience (Chief Financial Officer · Aug 1, 2011 – Aug 1, 2011 · Past); DMK Pharmaceuticals Corporation (Director · Feb 10, 2011 – Oct 16, 2013 · Past) | Director · Jan 3, 2011 – Jun 19, 2012 · Past |
| Kimberly Manhard Other companies: Connect Biopharma Holdings Limited (CHIEF DEVELOPMENT OFFICER · Since at least Nov 5, 2026); Inhibrx Biosciences, Inc. (Director · Since at least May 24, 2024); Inhibrx Inc (Director · Aug 18, 2020 – May 30, 2024 · Past); Heron Therapeutics, Inc. (EVP, Drug Development · Jan 10, 2014 – Apr 13, 2023 · Past) | SVP, Regulatory & Dev Ops · Oct 28, 2011 – Jun 19, 2012 · Past |
| David T Hagerty Other companies: Histogen Inc (EVP, Clinical Development · Oct 1, 2014 – Feb 7, 2019 · Past) | Senior VP & CMO · Dec 16, 2011 – Jun 19, 2012 · Past |
Log in to ask 6ix AI your own questions about Ardea Biosciences Inc.